Moreover, CD4 CAR T cells demonstrated potent tumor eradication ability and long-term efficacy in contrast to their CD8 counterparts, which exhibited short-term effector functions, becoming rapidly exhausted upon encountering the tumor cells. This evidence concerns the gene CD8A and neoplasm.